Skip to Content

BMS 140 857 (Sprycel 140 mg)

Generic Name: dasatinib

Pill with imprint BMS 140 857 is White, Round and has been identified as Sprycel 140 mg. It is supplied by Bristol-Myers Squibb.

Sprycel is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 140 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 140 857

Sprycel

Generic Name
dasatinib
Imprint
BMS 140 857
Strength
140 mg
Color
White
Size
11.00 mm
Shape
Round
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb
National Drug Code (NDC)
00003-0857
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.